16 May 2015
New findings, which were announced by the American Society of Clinical Oncology (ASCO) at its annual meeting, suggest that cancer treatment is advancing.
According to its report, a widely available vitamin pill can reduce the risk of non-melanoma skin cancers, while early-stage chemotherapy can extend the lives of men with advanced prostate cancers.
There are also new therapies that can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma.
ASCO president Dr Peter Paul Yu said: "In just four studies, we see the potential to spare thousands of people the stress and complications of a new cancer diagnosis, and to extend the lives of children and adults facing cancer in its most daunting forms."
Dr Gregory A. Masters, chair of ASCO's Cancer Communications Committee, said a deeper understanding of cancer biology and an era of cutting-edge precision medicine is helping improve the lives of patients with this disease.
Posted by Jeanette Royston
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.